WHO pre-qualifies Ranbaxy's anti-AIDS dose

[Guest guest]

WHO pre-qualifies Ranbaxy's anti-AIDS dose

The World Health Organisation (WHO) has pre-qualified Ranbaxy's

three-drug fixed dose anti-retroviral (ARV) combination products,

Triviro-LNS 30 and 40mg tablets.

According to the release issued to the BSE today, this product, a

bio equivalent to the individual innovators' drugs, has been

available in several developing countries and in India for nearly

two years.

Triviro-LNS is a combination of two nucleoside reverse transcriptase

inhibitors and a non-nucleoside reverse transcriptase inhibitor, the

release said.

The product is a comprehensive first line anti retroviral treatment

for HIV positive patients, the release added.(PTI)

http://www.business-standard.com/updates/news.asp?story=6826